Portfolio 2009
Company: Fabpulous B.V. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2009
Status: Active
Fabpulous develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability (lateral flow). The first application is a rapid h-FAPB test as an aid in the early diagnosis of a heart infarct.
Company: Cavadis B.V. - Visit website
Fund: Thuja Capital Healthcare Seed Fund I
Year: 2009
Status: Active
Cavadis is a biomarker company aiming to develop in vitro diagnostics for cardiovascular risk assessment.